Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag on the page has been updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov page. This reflects a minor backend update to the page rather than any change to the study details or enrollment information.
    Difference
    0.1%
    Check dated 2026-08-12T18:22:13.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4. This indicates a minor content update without changing study details.
    Difference
    0.1%
    Check dated 2026-07-28T05:37:42.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a newer release of the page. This is an internal version update and does not modify the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-06T18:17:29.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a deployment/patch update. No substantive study content or page details are affected.
    Difference
    0.1%
    Check dated 2026-06-29T15:37:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', signaling that enrollment for this study has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was adjusted along with a release note for Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:40:47.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page revision changed from v3.5.4 to v3.5.5, representing a minor update to the ClinicalTrials.gov page rather than a modification of the study data.
    Difference
    0.1%
    Check dated 2026-06-08T05:33:49.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.